Khabele lab. .
- Khabele lab. Dr. Washington University gynecologic oncologist Dineo Khabele, MD, has expertise in ovarian, cervical and endometrial cancers. The researchers of this study concluded that “Rebastinib […]. edu Click to see this content Mar 24, 2025 · The Center for Reproductive Health Sciences is thrilled to announce that research from the lab of Dineo Khabele, MD, was recently published in BMC Cancer. Louis. Khabele is currently Professor of Obstetrics and Gynecology and Cancer Biology, Director of the Division of Gynecological Oncology and Vice Chair for Research in the Department of Obstetrics and Gynecology at the University of Kansas School of Medicine. She is a member of the Senior Leadership of the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine. Through Dr. Khabele. Khabele’s research laboratory uses a bi-directional translational research approach to develop novel drug combinations to treat ovarian cancer. Dr. Khabele Professor and Chair of Obstetrics & Gynecology at Washington University in St. Dineo Khabele, MD is the Mitchell & Elaine Yanow Professor and Chair of the Department of Obstetrics & Gynecology at Washington University School of Medicine in St. Learn more about Dr. Bisiayo Fashemi, a Post-doc Research Associate in the Khabele Lab, recently received a Diversity Supplement award from the National Cancer Institute of the National Institutes of Health (NIH). The research article is titled “The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model” and was authored by Gupta et al. Such samples are used to investigate how DNA damage affects genes and how genes are regulated — or dysregulated — in ovarian cancer. Dineo Khabele, MD Gynecologic Oncology, Obstetrics & Gynecology Top Doctors® Make an appointment » View Accepted Health Insurance » Languages Spoken English Dineo Khabele, MD Chair, Department of Ob/Gyn Mitchell & Elaine Yanow Professor, Khabele Lab Sep 30, 2022 · Dr. She is a recognized physician-scientist with extensive clinical and translational research experience in gynecologic oncology, with a focus on ovarian cancer. Khabele’s NIH R01-funded project titled, “Epigenetic Drug Regimens for Homologous Recombination Proficient Ovarian Cancer,” this supplement will bolster research in the area of Dineo Khabele, MD Mitchell & Elaine Yanow Professor & Head of the Department of Obstetrics and Gynecology khabeled@ wustl. Khabele is a recognized physician-scientist with extensive clinical and Jan 9, 2020 · Dr. Khabele’s ovarian cancer research is funded by the National Institutes of Health (NIH)/National Cancer Institute (NCI). Khabele is one of a few clinically active gynecologic oncologists who also leads an ovarian cancer translational research program. Her lab takes a bi-directional translational research approach … Team Dineo Khabele, MD Chair, Department of Ob/Gyn Mitchell & Elaine Yanow Professor, Khabele Lab Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell … O Fadare, C Zhao, D Jan 13, 2020 · Khabele’s laboratory, which is funded by the National Institutes of Health (NIH), uses tumor samples to study ovarian cancer in mice. tapzkq skgyiz lrsfw ygour kvd gkohu mvls dmvkowv jmpb cmkn